Christopher Barchak
Private Equity Investor chez Next47 (United Kingdom)
Provenance du réseau au premier degré de Christopher Barchak
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland.
11
| Private Company | Investment Managers | 11 |
Behaviometrics AB
 Behaviometrics AB Packaged SoftwareTechnology Services Behaviometrics AB provides real-time monitoring and security services. The firm operates as a behavioral biometrics security company targeting the fintech industry. Its products identify the user while working on a computer, logging in to a web service, or tapping away on a phone. The firm develops frictionless behavioral user verification and authentication services such as BehavioAion, which monitors keystroke and mouse behavior in real-time for continuous authentication; BehavioWeb, which use keystroke dynamics for backend consumer verification in online or mobile services; and BehavioMobile, which use gesture, PIN-pad, or typing behavior for smart phone applications. The company was founded by Nils Olov Ingvar Renberg, Kristofer Nygren, Neil Costigan, Peder Nordström, Leif Peder Nordström, and Jonas Johansson in 2006 and is headquartered in Stockholm, Sweden.
5
| Subsidiary | Packaged Software | 5 |
Eight Roads Capital Advisors (UK) Ltd.
 Eight Roads Capital Advisors (UK) Ltd. Investment ManagersFinance Eight Roads Capital Advisors (UK) Ltd (Eight Roads Capital Advisors) is a venture capital subsidiary of FIL Ltd. founded in 1969. The firm is headquartered in London.
4
| Subsidiary | Investment Managers | 4 |
Conor Venture Partners Oy
 Conor Venture Partners Oy Investment ManagersFinance Conor Venture Partners Oy (Conor) is a venture capital firm founded in 2005 by Manu Mäkelä and Sami Ahvenniemi. The firm is headquartered in Espoo, Finland.
2
| Private Company | Investment Managers | 2 |
Next47 (United Kingdom)
2
| Subsidiary | Investment Managers | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Christopher Barchak via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| CISCO SYSTEMS, INC. | Telecommunications Equipment | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Merrill Lynch International
 Merrill Lynch International Investment Banks/BrokersFinance Merrill Lynch International (MLI-UK) is a brokerage firm headquartered in London, UK. The firm was founded in 1988 and is a subsidiary of ML UK Capital Holdings Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. MLI-UK provides brokerage services to individual and retail clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree | |
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree | |
| New York University | College/University | Masters Business Admin | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| University of Barcelona | College/University | Doctorate Degree | |
| Escuela de Organización Industrial | College/University | Masters Business Admin | |
Aravis AG
 Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland. | Investment Managers | Private Equity Investor | |
OncoEthix SA
 OncoEthix SA Pharmaceuticals: MajorHealth Technology OncoEthix SA operates as a clinical stage biotechnology company which develops cancer drugs. Its products include OTX008, OTX015, and OTX009. The company was founded by Esteban Cvitkovic, Jeanne Kay Noel, Yves Paternot, and Patrice Herait in March 2007 and is headquartered in Luzern, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Bristol-Myers Squibb SARL
 Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France. | Medical Distributors | Corporate Officer/Principal | |
KN April 2020 AB
 KN April 2020 AB Packaged SoftwareTechnology Services Keylane Nordic AB supplies business critical enterprise software for insurance companies, captives, and brokers. The firm supplies web-based policy administration system and application services. The company was founded in 1993 and is headquartered in Stockholm, Sweden. | Packaged Software | Director/Board Member | |
Scint-X AB
 Scint-X AB Medical SpecialtiesHealth Technology Scint-X AB develops and manufactures structured and customized scintillator products for X-ray imaging. Its products are used in industrial and scientific, medical, non-destructive testing, intra-oral sensor, and other applications. The company was founded by Bo Hammrlund in January 2007 and is headquartered in Stockholm, Sweden. | Medical Specialties | Chairman | |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member | |
Ericsson AB
 Ericsson AB Information Technology ServicesTechnology Services Ericsson AB manufactures and markets telecommunications equipment and solutions for corporate, as well as individual clients. It develops, sells, and trades goods, products, and services in the field of radio technology. The company was founded in 1952 and is headquartered in Kista, Sweden. | Information Technology Services | Corporate Officer/Principal | |
| Université Paris Nanterre | College/University | Doctorate Degree | |
Mind-NRG SARL
 Mind-NRG SARL Medical/Nursing ServicesHealth Services Mind-NRG SARL specializes in research and development programs with focus on the treatment psychiatric and neurologic diseases. The company was founded in 2010 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | Chairman Director/Board Member | |
| Nokia Telecom AB | Corporate Officer/Principal | ||
Index Venture Management (US), Inc.
 Index Venture Management (US), Inc. Investment ManagersFinance Founded in 2011, Index Venture Management (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Index Venture Management SA | Investment Managers | Private Equity Investor Private Equity Investor Chief Tech/Sci/R&D Officer | |
Epsilon-3 Bio Ltd
 Epsilon-3 Bio Ltd Pharmaceuticals: OtherHealth Technology Epsilon-3 Bio Ltd. develops compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders. The company was founded by Martin W. Edwards, Konstantinos Efthymiopoulos, David J. Grainger and Christian De La Tour on June 18, 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
Neo4j, Inc.
 Neo4j, Inc. Packaged SoftwareTechnology Services Neo4j, Inc. develops and provides databases management system. Its solutions include fraud detection, graph based search, identity and access, master data management, network and it operations, recommendation engine, social network and retail. The company was founded by Emil Eifrem, Johan Svensson and Peter Neubauer in 2000 and is headquartered in San Mateo, CA. | Packaged Software | Chairman Director/Board Member | |
DMC Partners (London) Ltd.
 DMC Partners (London) Ltd. Investment ManagersFinance DMC Partners (London) Ltd. engages in investment activities. The firm intends to invest in China, Russia, Southeast Asia, Turkey and sub-Saharan Africa regions. The company founded by Edward Kirill Eisler, Samuel Jonathan Wisnia and Christopher Michael Barter and is headquartered in London, the United Kingdom. | Investment Managers | Chief Operating Officer | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
ForgePoint Capital Management LLC
 ForgePoint Capital Management LLC Investment ManagersFinance ForgePoint Capital Management LLC (ForgePoint Capital Management) is a venture capital firm founded in 2015 by Donald R. Dixon, William Lin and Juan Alberto Yépez. The firm is headquartered in San Mateo, California. | Investment Managers | Consultant / Advisor Private Equity Investor | |
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investment Managers | Founder | |
Janpix Holdings, Inc.
 Janpix Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Janpix Holdings, Inc. engages in provision of research and experimental development on biotechnology. The company was founded by Patrick T. Gunning and Cortes Pierre and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Sticky Ad, Inc.
 Sticky Ad, Inc. Information Technology ServicesTechnology Services Sticky Ad, Inc. is a development stage company. The company is headquartered in San Francisco, CA. | Information Technology Services | Director/Board Member | |
Yukin Therapeutics SAS
 Yukin Therapeutics SAS Pharmaceuticals: MajorHealth Technology Yukin Therapeutics SAS manufactures pharmaceutical preparations. The company was founded by Matthieu Coutet on June 29, 2018 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
VaxNewMo LLC
 VaxNewMo LLC BiotechnologyHealth Technology VaxNewMo LLC is an early-stage biotechnology company based in St. Louis, MO. The company is developing polysaccharide conjugate vaccines against serious bacterial threats using its proprietary bioconjugation platform. The omniose bioconjugate vaccine platform enables the precise enzymatic attachment of virtually any bacterial polysaccharide antigen to engineered carrier proteins within a single E. coli cell. The company is breaking through the barrier of limited range of bacterial vaccines that can be developed, while leveraging the already established benefits of bioconjugation. The company was founded by Mario Feldman, Christian Harding, and Christine Szymanski. Michael Timothy Cooke has been the CEO of the company since 2022. | Biotechnology | Chairman | |
| Pearl River Bio GmbH | Director/Board Member | ||
| Pega-One SAS | Director/Board Member | ||
| Nira Biosciences, Inc. | Director/Board Member | ||
| ALDENA THERAPEUTICS, INC. | Director/Board Member | ||
| Vimela Therapeutics Ltd. | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 21 |
| France | 8 |
| Royaume-Uni | 7 |
| Suède | 7 |
| Suisse | 6 |
Sectorielle
| Health Technology | 18 |
| Finance | 10 |
| Consumer Services | 7 |
| Technology Services | 7 |
| Electronic Technology | 2 |
Opérationnelle
| Director/Board Member | 154 |
| Private Equity Investor | 35 |
| Corporate Officer/Principal | 34 |
| Chairman | 16 |
| Independent Dir/Board Member | 16 |
Relations les plus connectées
| Insiders | |
|---|---|
| Michelangelo Volpi | 57 |
| Michèle Ollier | 40 |
| Freddy Mangum | 22 |
| Simon Charles Brockman Andrews | 17 |
| Sami Pekka Ahvenniemi | 16 |
| Bjørn Stray | 15 |
| Tony Zappalá | 14 |
| Daniel Bach | 13 |
| Andrew McClure | 12 |
| Susana Quintana-Plaza | 11 |
| Rémy Henri Luthringer | 10 |
| Richard S. Rimer | 10 |
| Gaurav Tuli | 9 |
| Jarkko Ilmari Penttilä | 9 |
| Salman Farmanfarmaian | 9 |
- Bourse
- Insiders
- Christopher Barchak
- Connexions Sociétés
